Abdominal obesity metabolic syndrome
Information
- Disease name
- Abdominal obesity metabolic syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02283242 | Completed | Phase 4 | Galantamine Effects in Patients With Metabolic Syndrome | March 2014 | February 2017 |
| NCT02353767 | Completed | Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome | January 2011 | February 2013 | |
| NCT02954588 | Completed | N/A | Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity | October 14, 2016 | August 8, 2020 |
| NCT03020186 | Completed | N/A | Effects of Green-MED Diet Via the Gut-fat-brain Axis | January 2017 | March 2019 |
| NCT01887119 | Terminated | Phase 4 | Aldosterone Antagonism and Microvascular Function | October 2013 | November 2018 |
| NCT01872182 | Terminated | Phase 3 | Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome | May 2013 | January 2015 |
| NCT02001376 | Unknown status | N/A | A Health Promotion Project for Workers at National Taiwan University Hospital | April 2011 | August 2020 |